IPGA in association with DCO INDIA DRUGS CONTROL FORUM organized an International Webinar on DESIGNER DRUGS

Indian Pharmacy Graduates’ Association National in association with DCO INDIA DRUGS CONTROL FORUM organized an International Webinar entitled “ DESIGNER DRUGS”  A modern day threat of future therapeutic agent, on 17th April, 2022.The National President Dr. Atul Nasa in his welcome address appreciated such events and expressed. That such events should be continued.Dr. S. Eswara Reddy, Jt. Drugs Cotroller of India (CDSCO, New Delhi), made his gracious presence available as Chief Guest to bless the young Pharmacy Sauls. The scientific session was presented by the Key Note Speaker Prof. Muralikrishnan Dhanasekeran, Auburn University (USA).While addressing a gathering of delegates close to 1000 including Youtube viewers, Prof. Muralikrishnan emphasized on the Designer Drugs and their applicability in Prophylactic, diagnostic and Therapeutic Scales. He also explained the in silico, invitro and invivo stages in the process of drug design followed by drug synthesis and evaluation.The event was graced by Lalit Kr Goel, Haryana, Rakesh Dahiya, Haryana S.K. Tiwari, Jharkhand under the leader ship of G. Koteshwar Rao, Telangana, Group Head, DCO India, Drugs Control Forum, Co-ordinator IPGA South Zone and President IPGA Telangana.Feed back from the delegates was taken and also the session was made open to Questions to make scientific embellishments possible.The webinar was indeed a nourishment to young brains of pharma proffessionals present during the session.Session ended with National Anthem and Dr. M.C. Nishit, Kerala has Co Ordinated entaire event.NPPA expert panel decides not to fix ceiling price of Clotrimazole...NPPA fixes Retail Price of 15 formulations: April 2022USFDA gives nod to Lupin for Desvenlafaxine ER tabletsDrug recall: Insulin Glargine recalled due to this reasonDCGI: Fourfold increase in Investigational New Drugs Applications in India4 Medical Devices Parks to come up in a total of 1,326 acresCDSCO Committee gives approval to Sun Pharma for RanibizumabE-Cigarettes using synthetic nicotine come under FDA oversightUSFDA authorises first C-19 diagnostic test using breath samplesLatest Notifications regarding Pharmaceuticals
https://thehealthmaster.com/2022/04/20/ipga-in-association-with-dco-india-drugs-control-forum-organized-an-international-webinar-on-designer-drugs/